• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

ASO Author Reflections: Is Adjuvant Therapy Necessary for All Patients with Invasive Mucinous Cystic Neoplasms of the Pancreas? Let's De-escalate.

作者信息

Wong Paul, Pollini Tommaso, Maker Ajay V

机构信息

Division of Surgical Oncology, Department of Surgery, University of California, San Francisco, CA, USA.

出版信息

Ann Surg Oncol. 2024 Nov;31(12):8352-8353. doi: 10.1245/s10434-024-15948-9. Epub 2024 Jul 30.

DOI:10.1245/s10434-024-15948-9
PMID:39080135
Abstract
摘要

相似文献

1
ASO Author Reflections: Is Adjuvant Therapy Necessary for All Patients with Invasive Mucinous Cystic Neoplasms of the Pancreas? Let's De-escalate.ASO作者反思：所有胰腺浸润性黏液性囊性肿瘤患者都需要辅助治疗吗？让我们降低治疗强度。
Ann Surg Oncol. 2024 Nov;31(12):8352-8353. doi: 10.1245/s10434-024-15948-9. Epub 2024 Jul 30.
2
ASO Author Reflections: Total Neoadjuvant Therapy with Chemotherapy Alone for Pancreatic Cancer?ASO作者反思：单纯化疗用于胰腺癌的全新辅助治疗？
Ann Surg Oncol. 2024 Sep;31(9):6203-6204. doi: 10.1245/s10434-024-15660-8. Epub 2024 Jun 22.
3
Distinct Indications for Adjuvant Therapy in Resected Invasive Mucinous Cystic Neoplasms of the Pancreas Compared with Pancreatic Ductal Adenocarcinoma.与胰腺导管腺癌相比，在切除的侵袭性黏液囊性胰腺神经内分泌肿瘤中辅助治疗的明确适应证。
Ann Surg Oncol. 2024 Nov;31(12):8276-8286. doi: 10.1245/s10434-024-15841-5. Epub 2024 Jul 27.
4
ASO Author Reflections: Response to Chemotherapy Differs between Precursor Epithelial Subtypes of Pancreatic Adenocarcinoma Arising from Intraductal Papillary Mucinous Neoplasms and may Warrant Tailored Treatment to Improve Outcomes.ASO作者反思：导管内乳头状黏液性肿瘤引发的胰腺导管腺癌前驱上皮亚型对化疗的反应不同，可能需要量身定制治疗方案以改善预后。
Ann Surg Oncol. 2024 Oct;31(10):7070-7071. doi: 10.1245/s10434-024-15784-x. Epub 2024 Jul 6.
5
Invasive intraductal papillary mucinous neoplasm: predictors of survival and role of adjuvant therapy.浸润性导管内乳头状黏液性肿瘤：生存预测因素和辅助治疗的作用。
HPB (Oxford). 2010 Sep;12(7):447-55. doi: 10.1111/j.1477-2574.2010.00196.x.
6
Evaluation of preoperative prognostic factors in patients with resectable invasive intraductal papillary mucinous carcinoma.评估可切除的浸润性导管内乳头状黏液性癌患者的术前预后因素。
Surgery. 2020 Dec;168(6):994-1002. doi: 10.1016/j.surg.2020.01.014. Epub 2020 Mar 3.
7
ASO Author Reflections: The Role of Neoadjuvant Chemotherapy in Invasive Intraductal Mucinous Neoplasms of the Pancreas.ASO作者反思：新辅助化疗在胰腺浸润性导管内黏液性肿瘤中的作用
Ann Surg Oncol. 2024 May;31(5):2967-2968. doi: 10.1245/s10434-024-15002-8. Epub 2024 Mar 14.
8
Perioperative Chemotherapy for Pancreas Cancer: Quo Vadis?胰腺癌围手术期化疗：何去何从？
Ann Surg Oncol. 2024 Jul;31(7):4176-4178. doi: 10.1245/s10434-024-15257-1. Epub 2024 Apr 23.
9
Resectable invasive IPMN versus sporadic pancreatic adenocarcinoma of the head of the pancreas: Should these two different diseases receive the same treatment? A matched comparison study of the French Surgical Association (AFC).可切除的浸润性胰腺导管内乳头状黏液性肿瘤（IPMN）与散发性胰头腺癌：这两种不同的疾病应接受相同的治疗吗？法国外科协会（AFC）的一项配对比较研究。
Eur J Surg Oncol. 2017 Sep;43(9):1704-1710. doi: 10.1016/j.ejso.2017.06.011. Epub 2017 Jun 29.
10
ASO Author Reflections: Systemic Immune-Inflammation Index (SII) as a Biomarker of Response to Neoadjuvant Therapy in Patients with Pancreatic Adenocarcinoma.ASO作者反思：全身免疫炎症指数（SII）作为胰腺腺癌患者新辅助治疗反应的生物标志物
Ann Surg Oncol. 2020 Mar;27(3):907-908. doi: 10.1245/s10434-019-08136-7. Epub 2019 Dec 10.

本文引用的文献

1
Are Positive Biopsy Margins in Melanoma Significant?: A Cohort Study of Micro- Versus Macroscopic Margin Status and Their Impact on Residual Disease and Survival.黑色素瘤活检切缘阳性是否具有重要意义？：一项关于微观与宏观切缘状态及其对残留疾病和生存影响的队列研究。
Ann Surg Oncol. 2025 Jan;32(1):474-481. doi: 10.1245/s10434-024-16301-w. Epub 2024 Oct 9.
2
Adjuvant therapy in invasive intraductal papillary mucinous neoplasm (IPMN) of the pancreas: a systematic review.胰腺浸润性导管内乳头状黏液性肿瘤（IPMN）的辅助治疗：一项系统评价
Ann Transl Med. 2019 Nov;7(22):689. doi: 10.21037/atm.2019.10.37.
3
Cyst Fluid Biosignature to Predict Intraductal Papillary Mucinous Neoplasms of the Pancreas with High Malignant Potential.
囊液生物标志物预测具有高恶性潜能的胰腺导管内乳头状黏液性肿瘤。
J Am Coll Surg. 2019 May;228(5):721-729. doi: 10.1016/j.jamcollsurg.2019.02.040. Epub 2019 Feb 19.
4
A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer.胰腺癌切除术后放化疗与单纯化疗的随机试验。
N Engl J Med. 2004 Mar 18;350(12):1200-10. doi: 10.1056/NEJMoa032295.